Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to -$2.1 million.

  • Bioharvest Sciences' Cash from Operations fell 1887.44% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year decrease of 101.52%. This contributed to the annual value of -$6.7 million for FY2024, which is 2156.77% up from last year.
  • As of Q3 2025, Bioharvest Sciences' Cash from Operations stood at -$2.1 million, which was down 1887.44% from -$1.5 million recorded in Q2 2025.
  • Bioharvest Sciences' 5-year Cash from Operations high stood at -$958000.0 for Q2 2024, and its period low was -$3.0 million during Q4 2023.
  • Its 3-year average for Cash from Operations is -$1.7 million, with a median of -$1.6 million in 2024.
  • Examining YoY changes over the last 5 years, Bioharvest Sciences' Cash from Operations showed a top increase of 2020.71% in 2024 and a maximum decrease of 7678.39% in 2024.
  • Over the past 3 years, Bioharvest Sciences' Cash from Operations (Quarter) stood at -$3.0 million in 2023, then grew by 20.21% to -$2.4 million in 2024, then grew by 12.47% to -$2.1 million in 2025.
  • Its last three reported values are -$2.1 million in Q3 2025, -$1.5 million for Q2 2025, and -$1.4 million during Q1 2025.